A Retrospective Cohort Study of Intravenous Immunoglobulin Therapy in the Acute Phase of Kawasaki Disease: The Earlier, the Better?

Figure 1

The time of IVIG treatment and the patients with coronary artery abnormalities due to Kawasaki disease in 12 months follow-up. Shown are receiver-operating-characteristic (ROC) curves for days of illness with IVIG treatment and coronary artery abnormalities in 12 months follow-up with KD cohorts. The best days of IVIG treatment cut-off values for predicting coronary artery abnormalities were 7.5 days. The area under the curve (AUC) was 0.80 (95% CI, 0.76 to 0.84).